Skip To Main Content

HLA-A2-MAGE-A4 x CD3

(RG6129)

Solid Tumor

Phase I

A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors

NCT05129280